Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats-Reference-Cited by-同舟云学术

Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats

Published:2018-09-29 Issue:6 Volume:36 Page:e12466
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Zhang Kai¹,Ma Zuowang¹,Wang Weiding¹,Liu Ruimeng¹,Zhang Yue¹,Yuan Meng¹,Li Guangping¹^ORCID

Affiliation:

1. Tianjin Key Laboratory of Ionic‐Molecular Function of Cardiovascular Disease Department of Cardiology Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University Tianjin China

Funder

National Natural Science Foundation of China

Tianjin Science and Technology Committee

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1755-5922.12466

Reference28 articles.

1. Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal

2. Atrial remodeling, fibrosis, and atrial fibrillation

3. The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay

4. Obstructive Sleep Apnea and Atrial Arrhythmogenesis

5. Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia preconditioning of adipose stem cell-derived exosomes loaded in gelatin methacryloyl (GelMA) promote type H angiogenesis and osteoporotic fracture repair;Journal of Nanobiotechnology;2024-03-15

2. Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea;Cells;2023-06-19

3. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome;Signal Transduction and Targeted Therapy;2023-05-25

4. Role of epigenetic abnormalities and intervention in obstructive sleep apnea target organs;Chinese Medical Journal;2023-03-20

5. Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection;Vascular Pharmacology;2022-06